Back to REGN
Kimelman & Baird, LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$20.9M
Q3 2026
Peak value
$20.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $30K |
| Q4 2025 | $242K |
| Q1 2026 | $8.4M |
| Q2 2026 | $17.3M |
| Q2 2026 | $17.3M |
| Q3 2026 | $20.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $20.9M | 27.6K | — | — |
| Q2 2026 | $17.3M | 27.7K | — | — |
| Q2 2026 | $17.3M | 27.7K | — | — |
| Q1 2026 | $8.4M | 10.9K | — | — |
| Q4 2025 | $242K | 314 | — | — |
| Q3 2025 | $30K | 54 | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B